Acromegaly vs Gigantism
How to tell Acromegaly and Gigantism apart when a board question makes them look alike.
Step 2 CK pairs are in open beta while clinical review finishes. Spot an issue? Tell us.
Status of open versus closed epiphyseal growth plates is the key separator between gigantism and acromegaly.
Side by side
Acromegaly presents in adults with enlarged hands or jaw, coarse facial features, and elevated IGF-1 after epiphyseal closure.
Gigantism presents before epiphyseal closure with excessive linear growth velocity and very tall stature for age with elevated IGF-1.
Growth hormone-secreting pituitary adenoma after growth-plate fusion causes soft-tissue and acral overgrowth rather than height gain.
Excess growth hormone before epiphyseal fusion drives accelerated long-bone growth and extreme final height.
Age-adjusted IGF-1 is elevated and oral glucose tolerance test fails to suppress growth hormone below about 1 ng/mL; pituitary MRI often shows macroadenoma.
Children show markedly elevated IGF-1 with nonsuppressible GH after oral glucose and bone age advanced relative to chronologic age; MRI evaluates pituitary adenoma.
The trap
Tall adults with large hands may be mislabeled as gigantism, but once epiphyses are fused the diagnosis is acromegaly; management still targets pituitary adenoma control and IGF-1 normalization.
The repair move
Next best step: confirm biochemical diagnosis with elevated age-adjusted IGF-1 and failed GH suppression after oral glucose, then obtain pituitary MRI and pursue transsphenoidal adenoma resection as first-line therapy when operable. If residual disease persists, add a somatostatin analog such as octreotide LAR 20 mg IM every 4 weeks and titrate by IGF-1 response.
Try a free question
CoreA 43-year-old man reports enlarging shoe size and snoring with coarse facial changes. BP 144/86 mm Hg, HR 82/min, temp 36.7 C. IGF-1 is elevated for age. What is the next best step in management?
Show answer and explanation
Answer: A. Perform oral glucose suppression testing for GH and then pituitary MRI if abnormal. Elevated IGF-1 requires biochemical confirmation of GH excess, followed by pituitary imaging to direct treatment.
Why the other choices are tempting
- B. Wrong because adult presentation with fused growth plates indicates acromegaly physiology, not GH deficiency.
- C. Wrong because diabetes treatment alone does not address the pituitary source.
- D. Wrong because thyroid imaging does not evaluate suspected GH adenoma.
- E. Wrong because untreated acromegaly increases cardiometabolic morbidity.
Flashcards
Tap a card to flip it.
Which physiological feature separates gigantism from acromegaly most directly?
Open epiphyseal growth plates indicate gigantism; closed plates indicate acromegaly.
What biochemical screening test is first-line for both suspected acromegaly and gigantism?
Measure age-adjusted IGF-1 as the initial screening test.
Quick answers
What is the fastest way to tell Acromegaly from Gigantism?
Status of open versus closed epiphyseal growth plates is the key separator between gigantism and acromegaly.
What is the key clue for Acromegaly?
Acromegaly presents in adults with enlarged hands or jaw, coarse facial features, and elevated IGF-1 after epiphyseal closure.
What is the key clue for Gigantism?
Gigantism presents before epiphyseal closure with excessive linear growth velocity and very tall stature for age with elevated IGF-1.
What is the common trap with Acromegaly vs Gigantism?
Tall adults with large hands may be mislabeled as gigantism, but once epiphyses are fused the diagnosis is acromegaly; management still targets pituitary adenoma control and IGF-1 normalization.